First published · Last updated
TG2-Inhibition erhält ein neuroprotektiv assoziiertes mukosales Transkriptionsprogramm während Glutenexposition bei Zöliakie
A journal article published 2026-08-01 reports that inhibiting transglutaminase 2 (TG2) preserves a mucosal transcriptional program associated with neuroprotection during gluten exposure in celiac disease.
Categories: science-and-space, public-health
Generated scores
Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.
- Confidence
- 6/10
- Geographic reach
- 1/10
- Global importance
- 3/10
- Impact magnitude
- 3/10
- Positivity
- 7/10
- Urgency
- 2/10
Why it matters
The paper presents a molecular finding relevant to celiac disease that the source frames as neuroprotective.

